Cargando…
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716314/ https://www.ncbi.nlm.nih.gov/pubmed/34973599 http://dx.doi.org/10.1016/j.preghy.2021.11.002 |
| _version_ | 1784624299705892864 |
|---|---|
| author | Jayaram, A. Buhimschi, I.A. Buhimschi, C.S. |
| author_facet | Jayaram, A. Buhimschi, I.A. Buhimschi, C.S. |
| author_sort | Jayaram, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8716314 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87163142021-12-30 Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9 Jayaram, A. Buhimschi, I.A. Buhimschi, C.S. Pregnancy Hypertens Article Elsevier 2022-03 2021-11-25 /pmc/articles/PMC8716314/ /pubmed/34973599 http://dx.doi.org/10.1016/j.preghy.2021.11.002 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Jayaram, A. Buhimschi, I.A. Buhimschi, C.S. Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9 |
| title | Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9 |
| title_full | Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9 |
| title_fullStr | Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9 |
| title_full_unstemmed | Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9 |
| title_short | Letter #1 Response to letter to Editor by Dr. Sarkar et al. for’ who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for’ is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?’ Refers to PII: S2210-7789(21)00538-9 |
| title_sort | letter #1 response to letter to editor by dr. sarkar et al. for’ who said differentiating preeclampsia from covid-19 infection was easy? refers to pii: s2210-7789(21)00539-0 letter #2 response to letter to editor by dr. hantoushzadeh et al. for’ is covid-19 disease a risk factor for preeclampsia? should aspirin be considered for prophylaxis of preeclampsia in these patients?’ refers to pii: s2210-7789(21)00538-9 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716314/ https://www.ncbi.nlm.nih.gov/pubmed/34973599 http://dx.doi.org/10.1016/j.preghy.2021.11.002 |
| work_keys_str_mv | AT jayarama letter1responsetolettertoeditorbydrsarkaretalforwhosaiddifferentiatingpreeclampsiafromcovid19infectionwaseasyreferstopiis2210778921005390letter2responsetolettertoeditorbydrhantoushzadehetalforiscovid19diseaseariskfactorforpreeclampsiashouldaspirinbeconsid AT buhimschiia letter1responsetolettertoeditorbydrsarkaretalforwhosaiddifferentiatingpreeclampsiafromcovid19infectionwaseasyreferstopiis2210778921005390letter2responsetolettertoeditorbydrhantoushzadehetalforiscovid19diseaseariskfactorforpreeclampsiashouldaspirinbeconsid AT buhimschics letter1responsetolettertoeditorbydrsarkaretalforwhosaiddifferentiatingpreeclampsiafromcovid19infectionwaseasyreferstopiis2210778921005390letter2responsetolettertoeditorbydrhantoushzadehetalforiscovid19diseaseariskfactorforpreeclampsiashouldaspirinbeconsid |